Gut microbiota dysbiosis has been repeatedly observed in obesity and type 2 diabetes
mellitus, two metabolic diseases strongly intertwined with non-alcoholic fatty liver disease …

Non-alcoholic fatty liver disease (NAFLD) is an increasingly common condition associated
with type 2 diabetes (T2DM) and cardiovascular disease (CVD). Since systemic metabolic …

Background High ultra-processed food (UPF) consumption is associated with the
development of various diet-related non-communicable diseases, especially obesity and …

Background: A hypoxic microenvironment may induce angiogenesis and promote the
development of hepatocellular carcinoma (HCC). The aim of this study was to evaluate …

Various β-galactosidase enzymes catalyze the trans-glycosylation reaction with lactose. The
resulting galactooligosaccharide (GOS) mixtures are widely used in infant nutrition to …

Background Nonalcoholic fatty liver disease (NAFLD) is common among severely obese
patients. Two-dimensional shear wave elastography (2D-SWE) has been validated as a …

Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver
disorders in industrialized Western countries. The prevalence of the disease is estimated to …

Non-alcoholic fatty liver disease (NAFLD), which has a global prevalence of 20%–33%, has
become the main cause of chronic liver disease. Except for lifestyle medication, no definitive …

Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major
public health concern that is exacerbated by the obesity pandemic. Dietary interventions …

For decades, parenteral nutrition (PN) has been a successful method for intravenous
delivery of nutrition and remains an essential therapy for individuals with intolerance of …